Stay updated on Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    11%
    Check dated 2025-10-05T10:21:33.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:18:46.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now shows revision v3.0.2, replacing the previous v3.0.1; the Back to Top link has been removed.
    Difference
    0.6%
    Check dated 2025-09-13T17:38:07.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.6%
    Check dated 2025-09-06T15:04:55.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and country listings.
    Difference
    23%
    Check dated 2025-08-30T11:49:09.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:36:29.000Z thumbnail image

Stay in the know with updates to Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.